Search

everythinglearnresearchcommunity

for

Search:↓

Using umbilical cord stem cells can help create hair-growing tissues more affordably.

Transplanted rat hair follicles grew hair and had increased but not fully restored nerve connections in mice.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Chemotherapy drugs can cause abnormal growth and changes in healthy skin and gland cells.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Stem cell vesicles reduced eczema symptoms in mice safely.

Using bioreactors, scientists can grow more skin stem cells that keep their ability to regenerate skin and hair.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Current hair regeneration methods show promise but face challenges in maintaining cell effectiveness and creating the right environment for hair growth.

iPSCs show promise for hair regeneration but need more research to improve reliability and effectiveness.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

A new delivery system makes Curcumin more effective and safer against viruses.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Scalp micropigmentation, a cosmetic tattoo technique, is a promising non-surgical treatment for hair and scalp deformities, despite potential complications.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Current research on seborrheic dermatitis highlights key focus areas and suggests future study directions.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Six genetic conditions are often linked to complete scalp hair loss in children.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.